- £220.54m
- £731.52m
- $1.49bn
- 52
- 99
- 11
- 54
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,646 | 864 | 1,266 | 1,854 | 1,487 |
Cost of Revenue | |||||
Gross Profit | 403 | 76.5 | 366 | 653 | 541 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,114 | 1,174 | 686 | 1,476 | 1,090 |
Operating Profit | -468 | -310 | 580 | 378 | 397 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -729 | -566 | 352 | 203 | 232 |
Provision for Income Taxes | |||||
Net Income After Taxes | -449 | -470 | 377 | 185 | 85.6 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -449 | -470 | 377 | -41.2 | -30.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -449 | -470 | 377 | -41.2 | -30.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.405 | -0.075 | 0.229 | 0.303 | 0.148 |
Dividends per Share |